Role of heparin-binding epidermal growth factor-like growth factor in light-induced photoreceptor degeneration in mouse retina

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 6, 2013, Pages 3815-3829

  Inoue, Yuki ^a   Tsuruma, Kazuhiro ^a   Nakanishi, Tomohiro ^a   Oyagi, Atsushi ^a   Ohno, Yuta ^a   Otsuka, Tomohiro ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Age related macular degeneration; Heparin binding epidermal growth factor like growth factor (HB EGF); Light induced retinal degeneration; Neuroprotection; Photoreceptor

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; GENETIC TRANSFECTION; HISTOLOGY; IRRADIATION; MALE; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA DEGENERATION; RETINA INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; WESTERN BLOTTING;

AGE-RELATED MACULAR DEGENERATION; HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR (HB-EGF); LIGHT-INDUCED RETINAL DEGENERATION; NEUROPROTECTION; PHOTORECEPTOR;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; ELECTRORETINOGRAPHY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGHT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOTORECEPTOR CELLS, VERTEBRATE; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DEGENERATION;

EID: 84878639615     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11236     Document Type: Article

References (50)

1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358:2606-2617.
2. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966;5:450-473.
3. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275-306.
4. Yang JH, Basinger SF, Gross RL, Wu SM. Blue light-induced generation of reactive oxygen species in photoreceptor ellipsoids requires mitochondrial electron transport. Invest Ophthalmol Vis Sci. 2003;44:1312-1319.
5. Li ZY, Tso MO, Wang HM, Organisciak DT. Amelioration of photic injury in rat retina by ascorbic acid: a histopathologic study. Invest Ophthalmol Vis Sci. 1985;26:1589-1598.
6. Mandal MN, Patlolla JM, Zheng L, et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 2009;46:672-679.
7. Imai S, Inokuchi Y, Nakamura S, Tsuruma K, Shimazawa M, Hara H. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol. 2010;642: 77-85.
8. Shimazaki H, Hironaka K, Fujisawa T, et al. Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice. Invest Ophthalmol Vis Sci. 2011;52:7289-7297.
9. Yamauchi M, Tsuruma K, Imai S, et al. Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol. 2011;650:110-119.
10. Tanaka J, Nakanishi T, Ogawa K, et al. Purple rice extract and anthocyanidins of the constituents protect against light-induced retinal damage in vitro and in vivo. J Agric Food Chem. 2011;59:528-536.
11. Imai S, Shimazawa M, Nakanishi T, Tsuruma K, Hara H. Calpain inhibitor protects cells against light-induced retinal degeneration. J Pharmacol Exp Ther. 2010;335:645-652.
12. Nakazawa T, Tamai M, Mori N. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest Ophthalmol Vis Sci. 2002;43:3319-3326.
13. Liu Y, Gong Z, Liu L, Sun H. Combined effect of olfactory ensheathing cell (OEC) transplantation and glial cell line-derived neurotrophic factor (GDNF) intravitreal injection on optic nerve injury in rats. Mol Vis. 2010;16:2903-2910.
14. Sun X, Xu X, Wang F, et al. Effects of nerve growth factor for retinal cell survival in experimental retinal detachment. Curr Eye Res. 2007;32:765-772.
15. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. Pharmaco-kinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci. 2005;46:3800-3806.
16. Kyhn MV, Klassen H, Johansson UE, et al. Delayed administration of glial cell line-derived neurotrophic factor (GDNF) protects retinal ganglion cells in a pig model of acute retinal ischemia. Exp Eye Res. 2009;89:1012-1020.
17. Tanaka H, Ito Y, Nakamura S, Shimazawa M, Hara H. Involvement of brain-derived neurotrophic factor in time-dependent neurodegeneration in the murine superior collic-ulus after intravitreal injection of N-methyl-D-aspartate. Mol Vis. 2009;15:662-669.
18. Harada T, Harada C, Kohsaka S, et al. Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci. 2002;22:9228-9236.
19. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A. 1992;89: 11249-11253.
20. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251:936-939.
21. Mishima K, Higashiyama S, Nagashima Y, et al. Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain. Neurosci Lett. 1996;213:153-156.
22. Weuste M, Wurm A, Iandiev I, Wiedemann P, Reichenbach A, Bringmann A. HB-EGF: increase in the ischemic rat retina and inhibition of osmotic glial cell swelling. Biochem Biophys Res Commun. 2006;347:310-318.
23. Asakura M, Kitakaze M, Takashima S, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med. 2002;8:35-40.
24. Izumi Y, Hirata M, Hasuwa H, et al. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998;17:7260-7272.
25. Lemjabbar H, Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med. 2002;8:41-46.
26. Sunnarborg SW, Hinkle CL, Stevenson M, et al. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem. 2002; 277:12838-12845.
27. Yan Y, Shirakabe K, Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 2002;158:221-226.
28. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997;16:1268-1278.
29. Nakagawa T, Sasahara M, Hayase Y, et al. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat. Brain Res Dev Brain Res. 1998;108:263-272.
30. Kornblum HI, Zurcher SD, Werb Z, Derynck R, Seroogy KB. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. Eur J Neurosci. 1999;11:3236-3246.
31. Farkas LM, Krieglstein K. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons. J Neural Transm. 2002; 109:267-277.
32. Xia G, Lara-Marquez M, Luquette MH, Glenn S, Haque A, Besner GE. Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury. Antioxid Redox Signal. 2001;3:919-930.
33. Kuhn MA, Xia G, Mehta VB, Glenn S, Michalsky MP, Besner GE. Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal. 2002;4:639-646.
34. Hollborn M, Tenckhoff S, Jahn K, et al. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol Vis. 2005;11:397-413.
35. Wan J, Ramachandran R, Goldman D. HB-EGF is necessary and sufficient for Muller glia dedifferentiation and retina regeneration. Dev Cell. 2012;22:334-347.
36. Oyagi A, Oida Y, Kakefuda K, et al. Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS One. 2009;4:e7461.
37. Iwamoto R, Yamazaki S, Asakura M, et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A. 2003;100:3221-3226.
38. Zhu CC, Dyer MA, Uchikawa M, Kondoh H, Lagutin OV, Oliver G. Six3-mediated auto repression and eye development requires its interaction with members of the Groucho-related family of co-repressors. Development. 2002;129:2835-2849.
39. Furuta Y, Lagutin O, Hogan BL, Oliver GC. Retina- and ventral forebrain-specific Cre recombinase activity in transgenic mice. Genesis. 2000;26:130-132.
40. Tsuruma K, Shimazaki H, Ohno Y, et al. Metallothionein-III deficiency exacerbates light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2012;53:7896-7903.
41. Close JL, Liu J, Gumuscu B, Reh TA. Epidermal growth factor receptor expression regulates proliferation in the postnatal rat retina. Glia. 2006;54:94-104.
42. Dluz SM, Higashiyama S, Damm D, Abraham JA, Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J Biol Chem. 1993;268:18330-18334.
43. Lee KS, Park JH, Lee S, Lim HJ, Choi HE, Park HY. HB-EGF induces delayed STAT3 activation via NF-kappaB mediated IL-6 secretion in vascular smooth muscle cell. Biochim Biophys Acta. 2007;1773:1637-1644.
44. Prenzel N, Zwick E, Daub H, et al. EGF receptor trans-activation by G-protein-coupled receptors requires metal-loproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
45. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol. 2003; 163:489-502.
46. Li G, Anderson RE, Tomita H, et al. Nonredundant role of Akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death. J Neurosci. 2007;27:203-211.
47. Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell. 1992;69:1051-1061.
48. Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994;13:2322-2330.
49. Jin K, Sun Y, Xie L, Childs J, Mao XO, Greenberg DA. Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 2004;24:399-408.
50. Oyagi A, Morimoto N, Hamanaka J, et al. Forebrain specific heparin-binding epidermal growth factor-like growth factor knockout mice show exacerbated ischemia and reperfusion injury. Neuroscience. 2011;185:116-124.